News Breaks |
|
|
| October 12, 2012 |
| 16:05 EDT |  | WPI, SNY | Watson Pharmaceuticals unit receives FDA approval of generic Avapro Watson Pharmaceuticals (WPI) announced that its subsidiary Watson Laboratories, has received approval from the U.S. FDA on its Abbreviated New Drug Application for Irbesartan Tablets USP, 75 mg, 150 mg and 300 mg, the generic equivalent to Sanofi's (SNY) Avapro. Watson intends to begin shipping the product immediately. Avapro is indicated for the treatment of hypertension when used alone or in combination with other antihypertensive agents. It is also indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. For the 12 months ending August 31, Avapro and its generic equivalents had total U.S. sales of approximately $390M according to IMS Health data. |
|
|
News For WPI;SNY From The Last 14 Days Check below for free stories on WPI;SNY the last two weeks. |
|
|
| May 23, 2013 |
| 08:18 EDT |  | SNY | Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Subscribe for More Information |
|
| May 21, 2013 |
| 07:44 EDT |  | SNY | Sachs Associates to host a forum
Subscribe for More Information |
|
| May 20, 2013 |
| 17:26 EDT |  | SNY | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information |
|
| 11:27 EDT |  | SNY | Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva
Subscribe for More Information |
|
| May 17, 2013 |
| 08:03 EDT |  | SNY | Sanofi reports positive topline results from pivotal Phase III Jakarta study
Subscribe for More Information |
|
| 05:18 EDT |  | SNY | Sanofi says JAK2 inhibitor for myelofibrosis met primary endpoint
Subscribe for More Information |
|
| May 15, 2013 |
| 15:16 EDT |  | SNY | Sanofi systemic sclerosis treatment designated for orphan drug status
Subscribe for More Information |
|
| 05:39 EDT |  | SNY | Sanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information |
|
| May 13, 2013 |
| 09:44 EDT |  | SNY | Several companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information |
|
| 07:30 EDT |  | SNY | TechConnect to host a summit 2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. |
| |
| May 10, 2013 |
| 11:48 EDT |  | SNY | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
|
|
|
|